Drugs & Targets Novartis Kisqali receives positive CHMP opinion for HR+/HER2- locally advanced or metastatic breast cancer June 30, 2017Vol.43 No.26
Drugs & Targets Novartis receives EU approval for Zykadia in ALK-positive advanced non-small cell lung cancer June 30, 2017Vol.43 No.26
Drugs & Targets FDA approves Tafinlar and Mekinist for NSCLC with BRAF V600E mutation June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves first companion diagnostic test to screen for multiple NSCLC therapies June 23, 2017Vol.43 No.25
Drugs & Targets FDA rejects Pfizer’s marketing application for Epogen biosimilar June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients June 23, 2017Vol.43 No.25
Drugs & Targets FDA accepts Amgen’s application to expand indication for Xgeva June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves Darzalex as combination therapy for multiple myeloma June 16, 2017Vol.43 No.24
